Status:
COMPLETED
Uterine Rupture After Hysteroscopic Septum Resection
Lead Sponsor:
Università degli Studi dell'Insubria
Collaborating Sponsors:
University of Ljubljana
Università degli Studi di Brescia
Conditions:
Septum; Uterus
Rupture, Uterine
Eligibility:
FEMALE
18-48 years
Brief Summary
To date, several studies have already confirmed a positive effect of hysteroscopic metroplasty on reproductive outcomes in primary infertile women affected by uterine septum, the most common uterine m...
Eligibility Criteria
Inclusion
- Previous hysteroscopic septum resection;
- Pregnancy;
- Uterine rupture.
Exclusion
- Previous myomectomy (regardless of the surgical technique) or cesarean section.
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2021
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT04449640
Start Date
July 1 2020
End Date
April 1 2021
Last Update
April 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Antonio Simone Laganà
Ljubljana, Italy